Synthesis and characterization of Cu(II)-based anticancer chemotherapeutic agent targeting topoisomerase Iα: In vitro DNA binding, pBR322 cleavage, molecular docking studies and cytotoxicity against human cancer cell lines

New Cu(II)-based anticancer chemotherapeutic drug candidate was designed and synthesized as Topo I inhibitor to act as a potential antitumor agent.